Source: http://lawsdocbox.com/US_Government_Resources/78786858-Corporate-governance-framework-version-3.html
Timestamp: 2018-06-24 12:29:06
Document Index: 330722336

Matched Legal Cases: ['art 3', 'art 3', 'art 6', 'art 6', 'art 6', 'art 6']

Corporate Governance Framework. Version 3 - PDF
Download "Corporate Governance Framework. Version 3"
1 Corporate Governance Framework Version 3 7 th of December
3 Table of Contents 1. Introduction Purpose and Scope of the document Overview of the PSI Governing Legislation Functions of the PSI Mission, Vision and Values Strategic Direction and Business Planning Corporate Strategy Business Planning Annual Report External Stakeholders Customer Charter Transparency and public consultation Structure of the PSI PSI Council Committees of the Council Organisational Structure Council Council s accountability Collective and Individual Responsibilities of Council Members Effectiveness of Council Functions of the Council and their delegation Failure of Council to perform a function Role of the President Role of the Vice-President Advisory Committees of the Council Procedure for appointment of Advisory Committees of Council
4 7.2 Period of Appointment to Advisory Committees and Rotation Effectiveness of Advisory Committees of Council Responsibilities of Advisory Committee Members Key Roles and Functions of the Registrar (Chief Officer), senior management team and employees of the PSI Appointment of the Registrar Appointment of an Acting Registrar Temporary vacancy in the Office of Registrar Specific functions, powers and obligations of the Registrar Role of the Senior Management Team Role of PSI employees Codes of Conduct, Ethics in Public Office, Disclosure of Interests and Protected Disclosures Code of Conduct for Council and Advisory Committee Members of the PSI Breaches of Conduct identified by Council or Advisory Committee Members Code of Conduct for Employees of the PSI Breaches of conduct identified by employees of the PSI Disclosure of certain interests Gifts and Hospitality Ethics in Public Office Act, 1995 and Protected Disclosure Act Non-compliance with statutory obligations Conflict Resolution Meetings and Procedures of the PSI Council Standing Orders of Council Chairing of meetings Public Access to Meetings of Council Designation of items as confidential Prohibition of unauthorised disclosure of confidential information
5 10.6 Publishing of Council proceedings Induction for new Council Members Relationship between Council and Employees of the PSI Access to information by Council Members Professional Advice Reimbursement and Expenses Assurance, Audit and Compliance Arrangements Business and Financial Reporting Assurance Framework Internal Audit Independent Audit Committee Risk Management Procurement Reporting on Compliance with Governance Standards Review and Approval of the Corporate Governance Framework Appendix A: Standing Orders of the Council of the Pharmaceutical Society of Ireland Appendix B: Standing Orders of the Advisory Committees of the Pharmaceutical Society of Ireland Appendix C: Matters reserved for Council Appendix D: Terms of reference of the Council Appendix E: Code of Conduct for Council and Advisory Committee Members of the Pharmaceutical Society of Ireland Appendix F: Code of Conduct for Employees of the Pharmaceutical Society of Ireland Appendix G: Principles of Quality Customer Service for Customers and Clients of the Public Service
6 1. Introduction As the regulator of pharmacists and pharmacies, the Pharmaceutical Society of Ireland (PSI) must at all times act to protect and promote, the health, safety and wellbeing of patients and the public by ensuring that pharmacy services are delivered in a competent, professional and ethical manner and in an appropriate environment to the highest standards of quality, care and best practice. The term corporate governance is generally understood to encompass how an organisation is managed, its corporate structure, its culture, its policies and strategies, and the ways in which it deals with its various stakeholders. Good corporate governance is a key element in improving efficiency and accountability as well as enhancing openness and transparency. A significant element of the Government s programme for health service reform is the strengthening of governance and accountability arrangements across the health system. Governance is the processes, structures and procedures in place to ensure that persons and organisation charged with responsibilities by Government, shareholders, stakeholders or members, carry out those responsibilities to the highest standards. Governance obligations are reflected in legislation and in codes of practice, guidance and guidelines. Good governance means: I. Focussing on the organisation s purpose and on outcomes for citizens and service users. II. Performing effectively in clearly defined functions and roles. III. Promoting values for the whole organisation and demonstrating the values of good governance through behaviour. IV. Taking informed, transparent decisions and managing risk. V. Developing the capacity and capability of the governing body to be effective. VI. Engaging stakeholders and making accountability real. Benefits of good governance: I. Improved transparency and accountability. The PSI performs its functions and duties in the public interest and is therefore accountable to the public. The PSI is also accountable to the Oireachtas for the exercise of its regulatory functions. II. Taking informed, transparent decisions and managing risk. III. Improved communication with stakeholders. IV. Good governance leads to good management, good performance, good stewardship of public money, good public engagement and, ultimately, good outcomes. 1.1 Purpose and Scope of the document In accordance with the Pharmacy Act 2007 (the Act) the Council shall from time to time adopt and publish a governance framework. The Council of the PSI adopted its first Corporate Governance Framework in
7 This document is intended as a guide to everyone in the PSI, and to the people we serve, on how we do our work and why we do it in the way we do. It also sets out our standards of conduct, our values and the governance systems, particular to the public sector, by which we operate. Therefore, its purpose is to draw together what we should do and what we must do in conducting our business and also equip us to get continually better at directing the PSI s resources in pursuit of its objectives in an appropriate manner. All staff, Council and Committee members have a role to play in assuring good governance, adherence to the Code of Practice for the Governance of State Bodies in the performance of their duties, as well as to PSI policies, procedures and circulars from Government departments. In preparing this document, the relevant provisions from the Pharmacy Act 2007 and the Rules made under it were taken into account. Specifically, Part 3 The Council of the Society and Schedule 1 The Council and its members and the PSI s employees provide the legal direction and the background to this document. The Council of the PSI will formally review the operation of the Corporate Governance Framework annually. The objective for this Corporate Governance Framework is to ensure that: The PSI s systems of accountability and responsibility, are effective, robust, transparent, and identifiable; and It evolves so that the PSI can better adapt to social, political, environmental and economic changes. The models of best practice that were consulted and used in the development and updating of this Corporate Governance Framework were: Department of Public Expenditure and Reform Code of Practice for the Governance of State Bodies (2016) Department of Public Expenditure and Reform A Corporate Governance Standard for the Civil Service (2015) Department of Public Expenditure and Reform Governance Framework (2016) Department of Public Expenditure and Reform Risk Management Guidance for Government Departments and Offices 2016 The Good Governance Standard for Public Services issued by the Independent Commission on Good Governance in Public Services Financial Reporting Council (2014) The UK Corporate Governance Code (London, FRC). IFAC/CIPFA (2014) Independent Framework: Good Governance in the Public Sector. (New York/London, IFAC/CIPFA) Independent Commission on Good Governance in Public Services, The (2004) The Good Governance Standard for Public Services (London, OPM/CIPFA). National Standards Authority of Ireland (2010) Code of Practice for Corporate Governance Assessment in Ireland (Dublin, NSAI). OECD Principles of Corporate Governance Ethics in Public Office Acts Data Protection Acts 1988 and 2003 Freedom of Information Act 2014 Companies Act 2014 The Ombudsman Act 1980 and the Ombudsman (Amendment) Act 2012 Protected Disclosure Act
8 2. Overview of the PSI 2.1 Governing Legislation The key functions and powers of the PSI are set out in Sections 7, 8 and 9 of the Pharmacy Act 2007 and the Statutory Rules, which underpin it. The general governance responsibilities of the PSI are outlined in Schedule 1 to the Act and the Registrar is responsible for ensuring compliance with these, subject to the direction of the Council. In addition, the Council also has powers conferred on it under Misuse of Drugs legislation, Medicinal Products legislation, Poisons legislation, Animal Remedies legislation, Irish Medicines Board Act and European legislation. Where any conflict appears to arise between this document and the legislation and the statutory instruments made under it, then the legislation takes precedence. The Pharmacy Act 2007 and the Statutory Rules are available to download from the PSI s website at 2.2 Functions of the PSI In conducting its business, the Council, Committees, Registrar and employees of the PSI should take cognisance of the PSI s broad organisational objectives and processes, which are as follows: To regulate the profession of pharmacy in the State, having regard to the need to protect, maintain and promote the health and safety of the public by: a) defining, developing and ensuring high professional standards; b) defining, developing and promoting professional best practice; c) assuring the quality of, and developing and promoting, pharmacy education and training; d) fostering and promoting the practice of pharmacy; e) ensuring the application of advances in pharmaceutical science knowledge to professional standards, professional best practice, and pharmacy education and training; and f) generating and managing resources. Under the Pharmacy Act 2007 the regulator s principal functions are to: Regulate the profession of pharmacy in the State having regard to the need to protect, maintain and promote the health and safety of the public; Promote and ensure high standards of education and training for persons seeking to become pharmacists, including continuing professional development and the acquisition of specialisation; Ensure that those persons and pharmacists obtain appropriate experience; Maintain registers of pharmacists and pharmacies and determine and apply the criteria for registration; Inspect pharmacy practices and enforce pharmacy legislation; Draw up codes of conduct for pharmacists and oversee the quality assurance and application of best practice across the sector; Conduct inquiries to determine fitness to practise and fitness to operate ; Process complaints relating to pharmacy practice and the operation of a pharmacy; 8
9 Act as the registration authority for pharmacists wishing to practise in Ireland who have obtained their qualification outside of Ireland and the European Union (EU); Act as the competent authority for mutual recognition of qualifications obtained in or recognised by Member States and for the purposes of the Professional Qualifications Directive; Give the Minister such information and advice about such matters relating to its functions as the Minister may call for; Take suitable action to improve the profession of pharmacy; and, Supervise compliance with the Pharmacy Act 2007 and the instruments made under it. 2.3 Mission, Vision and Values Our Vision That the public has access to trusted pharmacy services and that the PSI makes a clear and demonstrable contribution to the availability and quality of those services. Our Mission We protect and promote the health, safety and wellbeing of patients and the public by taking timely and effective action to ensure that pharmacists in Ireland are competent and that pharmacies are operating to a high standards of safety and reliability. Our Values Our values underpin how we deliver on our mission. They guide our behaviour, the expectations we set ourselves, and the experience of others who engage with us. They provide evidence as to our commitment to equality and human rights in how we fulfil our role. 3. Strategic Direction and Business Planning 3.1 Corporate Strategy In accordance with the Public Service Management Act 1997 and the PSI Council Rules 2008, as amended the PSI is required to prepare and submit a strategy statement to the Minister for Health. The Pharmacy 9
10 Act 2007 and the rules made under it provide that the Registrar of the PSI is responsible for the preparation of a Corporate Strategy for adoption by the Council, publication and submission to the Minister for Health. The Statement of Strategy should cover a period of 3-5 years ahead and should set out appropriate objectives and goals and identify relevant indicators and targets against which performance can be clearly measured. The Statement of Strategy should contain a mission statement, high level objectives and target outputs and outcomes in the key strategic areas of the PSI activity as well as a statement on the resources to be deployed to meet the targets. The Statement of Strategy should also be aligned to specific objectives in the parent Departments Strategy and consistent with any Government policies for the reform and modernisation of the public service. Process for setting strategy The PSI s Statement of Strategy is prepared based on wide consultation, both within the PSI and externally with our stakeholders. A copy of the draft strategic plan is submitted to the Minister for Health at least 12 weeks in advance of finalisation and adoption by the Council to ensure that Council can consider the views of the Minister. Once approved by the PSI Council, the Statement of Strategy is submitted to the Minister for Health. The Statement of Strategy is reviewed on a yearly basis to ensure that the objectives identified are being met, to reflect on achievements and to identify any obstacles or risks to achieving the remaining objectives. 3.2 Business Planning The development of an annual business plan is set down in Schedule 1, para. 22 of the Act. The strategic plan sets out the high-level objectives and targets of the PSI over 3-5 years whereas the annual business plan explains how the PSI will carry out specific actions, which will deliver the objectives set out in the strategic plan. The preparation and implementation of an annual business plan is central to guiding and monitoring progress at an organisational and individual level. The Council of the PSI approves the annual business plan and budget, and monitors performance by reference to the plan and budget on a quarterly basis. The PSI links its strategic and annual goals to the work of each staff member through the PSI s performance management and development process. This allows employees to see exactly how their individual work contributes to the corporate goals of the PSI. 3.3 Annual Report The development of an Annual Report and Financial Statements is set down in Schedule 1 of the Act. The Annual Report outlines the main achievements and developments during the year to advance the PSI s objectives, as set out in its Statement of Strategy. The Annual Report and Financial Statements provide the information necessary for an assessment of the PSI s financial performance, financial position, business model and strategy. Material for the Annual Report is provided by each Department of the PSI. Once approved by the Council of the PSI, the Annual Report is submitted to the Minister for Health, by 10
11 31 st of March each year, for approval and laying before the Houses of the Oireachtas. It is translated into Irish and published in both Irish and English on the PSI s website 4. External Stakeholders 4.1 Customer Charter The PSI is committed to providing a professional, efficient, courteous and high quality service to all our customers, in accordance with the 12 Principles of Quality Customer Service (Appendix G). We are committed to maintaining and improving the delivery of a high standard of service to our customers in the current challenging environment. We will treat all our customers equally and make every effort to ensure that the services we provide reflect their needs and expectations. The PSI has developed a Customer Charter to demonstrate our commitment to high quality customer service, which is available on the PSI s website. 4.2 Transparency and public consultation The PSI is committed to openness and transparency in all aspects of its work. The PSI s Publication Scheme under the Freedom of Information Act 2014 sets out detailed information on what the PSI is responsible for. Details of public consultations are also available at 5. Structure of the PSI 5.1 PSI Council The PSI is governed by a Council which consists of 21 persons appointed by the Minister of Health (Figure 1). The membership requirements of the Council are detailed in Part 3 of the Act. Of those 21: - One must be a representative nominated by the Health Products Regulatory Authority (HPRA) as representative of the management of the regulation of medicinal products; - One must be a representative nominated by the Health Services Executive (HSE) as representative of the management of the public health sector; - Nine must be representatives nominated by the Minister for Health and of those nine, one should represent the provision of continuing professional development (CPD) and three should have qualifications, expertise or experience to make a substantial contribution to the PSI s functions; - Nine must be representatives selected by members of the PSI and should be registered pharmacists; and, - One shall be a representative selected by the Schools of Pharmacy and must be a registered pharmacist. The structure of the PSI Council is illustrated in figure 1. The procedure for the election of pharmacist members to the Council is detailed in the Pharmaceutical Society of Ireland (Council) Rules 2008 and
12 Removal of a Council Member from office A Council member may be removed from office as provided under Schedule 1, para. 3 of the Act, by the Minister for Health if: a) in the Minister s opinion, the member has become incapable through ill health, of performing his or her functions; b) the member has committed stated misbehaviour; or c) the removal of the member appears to the Minister to be necessary for the Council to perform its functions effectively. Resignation of a Council member In the event that a Council member wishes to resign from the Council, they should write to the Minister for Health informing him/her of their resignation and send a copy of the letter to the President. The President should notify the Council of the resignation. The governance framework of the PSI illustrated in figure 2 shows the reporting mechanisms in existence in the PSI. The Act allows for the establishment of Advisory Committees and statutory Disciplinary Committees. 12
13 Figure 1: Structure of the PSI Council 13
14 Figure 2. Governance Framework of the PSI President of the Council Council Chief Officer/Registrar Senior Management Team Oireachtas Select Committee Audit and Risk Committee Advisory Committees Disciplinary Committees (Statutory process of reporting) Public Accounts Committee Department of Health Appoints/Gives direction PSI staff Reports to Provides 14 oversight Accountable to
15 5.2 Committees of the Council Disciplinary Committees A number of statutory Disciplinary Committees of the PSI are established under Part 6 of the Act. These are the Preliminary Proceedings Committee, Professional Conduct Committee and the Health Committee. These Committees and their operation are governed strictly by Part 6 of the Act and their business cannot be modified or compromised other than by statute. The Council is responsible for appointing individuals to serve on Disciplinary Committees. Any resignation of Disciplinary Committee members should be notified to the Chair of the Committee and the Council. Advisory Committees In addition to the Disciplinary Committees, which the Council must set up under Part 6, Section 34 of the Pharmacy Act 2007, it may establish Advisory Committees to advise it in relation to the performance of its functions and may determine their terms of reference and record the terms of reference in the minutes of the Council. Advisory Committees of Council are bound by all the obligations of Council. The period of membership of an Advisory Committee shall be fixed upon appointment to the Advisory Committee and shall not exceed 2 years. Any resignation of Advisory Committee members should be notified to the Chair of the Advisory Committee and the Council. Currently the PSI has six Advisory Committees as outlined below: 1. Administration and Finance Committee 2. Inspection and Enforcement Committee 3. Professional Development and Learning Committee 4. Registration and Qualification Recognition Committee 5. Pharmacy Practice Development Committee 6. *Audit and Risk Committee The Council has also established a Chairpersons forum, which consists of the Chairs of the Advisory Committee, the Vice President and the President. The terms of reference of these Committees can be found on the PSI website at *The Audit and Risk Committee has a dual role. As well as being an Advisory Committee to Council, it also examines the adequacy of the nature, extent and effectiveness of accounting and internal control systems within the PSI, to undertake the specific duties as outlined in its terms of reference and to support adherence to the principles of good governance throughout the PSI. 5.3 Organisational Structure The PSI is broken down into five Departments, Operations, Regulation, Education and Registration Pharmacy Practice Development and Corporate Governance and Public Affairs. The Heads of each of the Departments and the Registrar form the Senior Management Team, as illustrated in figure 3. 15
16 Corporate Governance and Public Affairs Department Corporate Governance The Corporate Governance and Public Affairs Department is responsible for implementing strategic management practices to enable the organisation s effectiveness and efficiency through robust annual business planning and reporting processes. The Department supports the Council and the organisation in the achievement of strategic and operational objectives and is also responsible for advising on and ensuring organisational compliance with legislative and corporate governance requirements, including Internal Audit, Risk Management, Freedom of Information and Data Protection. The Department also provides secretarial support to meetings of the PSI Council, Chairpersons Forum, Audit and Risk Committee and the Nominations Sub-Group. Communications and Public Affairs The Department is also responsible for the implementation of the Communications Strategy. This includes proactive engagement with the public, profession and other stakeholders, key influencers and decision makers, managing media relations on behalf of the Registrar and President, and advising on the development of material for internal and external communication. The Department also has responsibility for co-ordinating and managing corporate publications such as the Service Plan, Annual Report and Corporate Strategy and overseeing the management and response to parliamentary questions and public consultations. Education and Registration Department Professional Development and Learning The Professional Development and Learning Unit has responsibility for ensuring that pharmacy education and training is in line with best practice and the highest international standards. This includes producing rules, standards and arranging for the accreditation of educational programmes for the pharmacy profession at different levels, ensuring high standards of education and training, implementing a system of continuing professional development through the Irish Institute of Pharmacy, and overseeing remedial education activities as directed by Council following fitness to practise proceedings. Registration and Qualification Recognition The Registration and Qualification Recognition Unit has responsibility for ensuring that both Registers of Pharmacists and Pharmaceutical Assistants are robust and information contained therein is up to date. Its functions include the processing of applications through national, EU and Third Country routes of registration; the processing of certificates of professional status for registrants accessing registration in another jurisdiction; the management of adherence to conditions placed on the registration of individual registrants and assisting with registration related queries, as well as supporting the Registration and Qualification Recognition Committee. Pharmacy Practice Development Department The Pharmacy Practice Development Department is responsible for the promotion of best practice standards and the improvement of pharmacy practice through the development of guidance and in the 16
17 provision of a query management service to pharmacists. The Department also engages with stakeholders to help optimise the role of pharmacists, and thereby achieve improvements in quality of care to patients. Regulation Department Inspection and Enforcement The Inspection and Enforcement Unit is responsible for the inspection of pharmacies and investigations of breaches of pharmacy or medicines legislation. It also oversees responsibility for the registration of retail pharmacy businesses and a newer function requiring establishment of an Internet Supply List under the Falsified Medicines Directive. Fitness to Practise and Legal Affairs The Fitness to Practise and Legal Affairs Unit is responsible for processing all complaints and expressions of concern from the public in a timely and efficient manner and supporting the organisation in relation to any legal matters. Operations Department Administration and Finance The Administration and Finance Unit is responsible for the management of the finances of the PSI in a prudent and efficient manner, ensuring that the Council fulfils its legislative requirements and applies best practice to the governance of its financial affairs. The Unit is also responsible for the management of the procurement function and facilities management in PSI House. ICT The ICT Unit is responsible for continuously monitoring and reviewing internal systems and processes in order to implement appropriate information and communications technologies to support expanding operations of the PSI. It does this through the delivery of technology, operations and services. The Unit is also responsible for disaster recovery and business continuity. Human Resources The Human Resource (HR) Office is responsible for the provision of all HR services, systems, policies and procedures required to assist the PSI in maintaining a positive working environment for all employees that supports equality and diversity and encourages innovation and continuous improvement. 17
18 Figure 3. Organisational Structure of the PSI 18
19 6. Council 6.1 Council s accountability The PSI is a legal entity and, as such, has powers and duties under the Pharmacy Act These are exercised by the PSI as the legal entity, with the Council as governing body. The powers and responsibilities of the Council are exercised jointly by its members, each of whom therefore has statutory and fiduciary duties (i.e. the duty to act in good faith and in the best interests of the PSI) in discharging them. The Council is accountable for its policy decisions, for the overall performance of the organisation, for ensuring that the necessary organisational and management framework is in place and has a fiduciary duty in relation to the PSI, Councils affairs and finances. The PSI has public responsibilities and is ultimately accountable to the Minister for Health and the Oireachtas for the discharge of these, and therefore must always act within the context of the public benefit. The Council provides strategic guidance to the PSI, and monitors the activities and effectiveness of management. The Council is responsible for developing the capacity and leadership of PSI staff and is responsible for holding the Registrar and senior management to account for effective performance of their responsibilities. The preparation and adoption of a strategic plan is a primary responsibility of the PSI s Council. The Council should agree the PSI s strategic aims with the Minister and Department of Health, to the extent relevant, and ensure optimal use of resources to meet its objectives. The Council should develop the capacity and leadership of PSI staff The Council has a key role in setting the ethical tone of the PSI, not only by its own actions but also in overseeing senior management and staff. Council members should act on a fully informed basis, in good faith, with due diligence and care, and in the best interest of the PSI, subject to the objectives set by Government. The Council should lead by example and ensure that good standards of governance and ethical behaviours permeate all levels of the organisation. All Council members are required to support the integrity and probity of any proceeding taken under Part 6 of the Pharmacy Act 2007 (complaints, inquiries and discipline) and to maintain public and professional confidence in these proceedings. Council members should not become involved personally in specific cases and should not act as character witnesses in any such proceedings at any time. In addition, they should not generally give support to any application for restoration to the PSI s register after removal as a result of such proceedings. Council members may receive correspondence from individual pharmacists, or members of the public. In responding to any matters raised by stakeholders, care must be taken to reflect the Council s policies accurately, particularly when dealing with sensitive and personal issues and therefore Council members should forward any correspondence received by him or her to the Registrar s Office who will deal with such correspondence. 19
20 6.2 Collective and Individual Responsibilities of Council Members The Council is collectively responsible for promoting the success of the PSI by leading and directing the PSI s activities. All Council members should be afforded the opportunity to fully contribute to Council deliberations, and where necessary to provide constructive challenge, while excessive influence on Council decision-making by one or more individual members should be guarded against. Matters which are reserved for Council are outlined in Appendix C. Council members are collectively responsible for a decision even if they have voted against it, abstained from voting, or were absent. It follows that all Council members are bound by a decision of the Council made in good faith (whether a unanimous or majority decision) and may not obstruct or interfere with the promotion or execution of that decision. When they have done so, collective responsibility requires them to acknowledge the decision of the Council and uphold it whether or not they personally agree with it. Collective Responsibility of Council Members 1. Hold a stewardship role in relation to monitoring, implementation, corporate performance, planning, audit, service plan approval and implementation and due process for all the purposes of the Pharmacy Act 2007; 2. Ensure compliance with all statutory obligations applicable to the PSI that may be set out in legislation governing the establishment of the PSI or in other relevant legislation; 3. Ensure the integrity of PSI s accounting and financial reporting systems; 4. Ensure that appropriate systems of control are in place, in particular, systems for risk management, financial and operational control, compliance with the law and relevant standards, and confirm annually to the Minister for Health in the PSI s Annual Report that these are in place; 5. Fully engage in impartial and balanced consideration of all issues; 6. Exercise the prescribed regulatory and law enforcement duties; 7. Develop strategy and policy in the interests of the public, putting forward ideas and constructively building on them; 8. Monitor the implementation of policies and activities of Advisory Committees at a high level and assess the effectiveness of the agreed strategy; 9. Share corporate responsibility for all Council decisions; and be objective in their work on behalf of the Council; 10. Ensure that Council s relationship with the Registrar, employees of the PSI and external advisors operates effectively; and 11. Review the operation of Council and seek to identify ways of improving its effectiveness. Individual responsibility requires Council members to ensure they understand the matters that are put before them, to have the courage to challenge and be challenged and to give voice to their issues and concerns. When they have done so, collective responsibility requires them to acknowledge the decision of the Council and uphold it whether or not they personally agree with it. 20
21 Individual Responsibility of Council Members 1. Share corporate responsibility for all Council decisions; 2. Be objective in their work on behalf of Council; 3. On appointment to the Council, furnish to the Registrar details relating to their employment and all other business interests including shareholdings, professional relationships, etc., which could involve a conflict of interest or could materially influence the member in relation to the performance of their functions as a member of the Council; 4. Inform the Registrar, of any new appointments they accept which may impinge on, or conflict with, their duties as a member of the Council of the PSI; 5. Work effectively with fellow Council members so as to ensure that the PSI performs its functions as set down in the Pharmacy Act 2007, by monitoring the implementation of the Service Plan; 6. Support the Council s policies and views in a positive way to external audiences; 7. Take responsibility for addressing the items that appear on the agenda of Council meetings by: a. Reading the papers beforehand; b. Being disciplined enough not to deviate from the agenda item; c. Contribute to discussions with no personal objectives in mind; 8. Not to disclose, without the consent of the Council, save in accordance with law, any information obtained by him or her while performing duties as a member of the Council and after their term of office expires; 9. Treat papers marked for non-disclosure as confidential to themselves, not discuss them with others outside the Council of the PSI, not leave them unattended and where others may obtain access to them, and dispose of them appropriately; 10. Not to misuse information gained in the course of their service for personal or political gain; 11. Comply with all aspects of the Corporate Governance Framework, including the Code of Conduct (Appendix E) which includes their disclosure of all relevant interests; and 12. Act in good faith and in the best interests of the Council of the PSI. 6.3 Effectiveness of Council Good governance suggests that all governing bodies should undertake periodically an evaluation of board effectiveness. This is so as to ensure the organisation and the Council remains fit for purpose and an effective vehicle to implement the legal, regulatory and governance obligations of the organisation. The Council is committed to evaluating its performance and embracing initiatives which will assist in improving its overall effectiveness and leadership role within the PSI at the end of each year. The Council should constantly review its own operation and seek to identify ways of improving its effectiveness including the identification of competency gaps and consideration of ways to address these gaps. Where the Chairperson believes specific competency or skills are required, he/she should advise the Minister for Health sufficiently in advance of a time when a vacancy is due to arise. The Chairpersons Forum has a role in advising the President and the Registrar on how best to enhance the effectiveness of the Council in the transaction of its business, and should bring to Council on an annual basis, or more often if necessary recommendations that would improve the effectiveness of Council business. 21
22 6.4 Functions of the Council and their delegation Subject to the Pharmacy Act 2007, the functions of the PSI shall be performed on its behalf by the Council. The Council holds and retains overall responsibility for the discharge of the key functions specified in the Pharmacy Act It must comply with all statutory regulations and legal obligations which apply to the PSI. The Council is accountable to the Minister for Health and the public for the proper discharge of the functions of the Council. The Council may delegate any of its functions to any of its Advisory Committees or to the Registrar or to any other employee of the PSI and, where it delegates a function to a Committee, the Committee s remit under this Act shall be extended accordingly. Where the Council delegates a function, the Council still remain the accountable body. The Registrar is accountable to the Council for the implementation of the Council s policies. The Registrar in turn delegates or sub-delegates functions to the Senior Management Team (which consists of the Heads of each Department as outlined in Section 8.5). The day-to-day performance of all of the tasks associated with the work of the PSI is undertaken by the Registrar, management and employees of the PSI but subject to the policy, strategy and corporate authority of the Council and its Advisory Committees. 6.5 Failure of Council to perform a function If the Council fails to perform any of its functions, the Minister for Health may direct it in writing to perform the function within a specified timeframe. If the Council does not comply with the direction, the Minister may, by order, remove from office any or all of its members and perform the function him or herself. 6.6 Role of the President The Office of President is specified in the Pharmacy Act 2007 and must be filled by a pharmacist member of Council. The President of the Council is expected to observe the duties and responsibilities of the Council members but also has particular responsibility: 1. To chair the meetings of Council and ensure that the minutes of the meeting accurately record the decisions taken; 2. To agree, in consultation with the Registrar the agenda for Council meetings, 3. To ensure that all meetings of the Council are conducted in accordance with the Pharmacy Act 2007, PSI (Council) Rules 2008 (S.I. No. 492 of 2008, as amended) and the standing orders of the Council (Appendix A); 4. To ensure that Council members understand their respective roles and responsibilities and that Council works effectively and efficiently; 5. To ensure the Council receives accurate, timely and clear information. 6. To ensure, in conjunction with the Secretary to Council, that there is good information flows within the Council and its Committees and between the Executive and Council; 7. To chair meetings of the Chairpersons Forum; 22
23 8. To advise the Minister of any competency deficits on Council, to ensure that candidates with specific skills requirements can be identified through the State Boards appointments process; 9. To furnish a comprehensive report on the PSI to the Minister for Health in conjunction with the Annual report and Financial Statements; 10. To submit a report to the Minister as part of the Annual report on the Statement of Internal Control, which should be reviewed by the External Auditors to confirm that it reflects the PSI s compliance with paragraph 1.9 (iv) of the Code of Practice for the Governance of State Bodies (2016) and is consistent with the information of which they are aware from their audit of the financial statements; 11. When called upon, and following consultation with the Registrar, to communicate the Council s strategy and policies to the wider sector; 12. To promote the work of the Council in the public arena; 13. To represent and further, following consultation with the Registrar, the views of the Council at meetings with Ministers, Oireachtas Committees, leaders of other professions, and other pharmaceutical bodies; and 14. When requested to do so, to represent the PSI at meetings with groups such as Pharmaceutical Society of Northern Ireland (PSNI), International Pharmaceutical Federation (FIP), EU Commission, General Pharmaceutical Council (GPhC), other agencies and Government Ministers. The President may come into possession of or be privy to certain information which is highly confidential and which has been entrusted to him or her by virtue of his/her office. Such highly confidential may come into his/her possession prior to possession coming into that of the Council. The President shall ensure that such highly confidential information is only disclosed in accordance with due process and shall respect such highly confidential information when they leave office. 6.7 Role of the Vice-President The Office of Vice-President must be filled by a pharmacist member of the Council. The Vice-President deputises for the President in his or her absence, when requested to do so by the President. In the absence of the President, the Vice-President will chair meetings of the Council. The Vice-President should generally support the President. In so far as the Vice-President is deputising or carrying out the work of the President, he or she is obliged to reflect the same views as the President and the policy of the PSI Council. The Vice-President of the Council is expected to fulfill the duties and responsibilities of a Council Member. Following the agreement of the President and the approval of Council, he or she would discharge the following additional responsibilities: 1. To participate in and support the Chairpersons Forum; 2. To deputise for the President as may be required by the President and/or Council and on such other occasions as may be determined by the President and/or Council; 3. When requested to do so, to represent the PSI at meetings with groups such as Pharmaceutical Society of Northern Ireland (PSNI), International Pharmaceutical Federation (FIP), EU Commission, General Pharmaceutical Council (GPhC), other agencies and Government Ministers. 4. To support the President and Council in ensuring adequate representation of the PSI Council when deemed necessary by the President and/or Council; 5. When requested, to represent PSI on Committees of other regulators or statutory organisations. 23
24 6. When requested, to support the strategic policy implementation process in areas such as pharmacy practice development, continuing professional development, undergraduate and post-graduate education with relevant chairs; 7. When requested, to liaise with the Registrar, in relation to any other matters which the Council feels are appropriate in the absence of the President; and 8. To chair certain of the Council Advisory Committees/Working Groups as may be appropriate when nominated by the President and appointed by the Council to do so. The Vice-President may come into possession of or be privy to certain information which is highly confidential and which has been entrusted to him or her by virtue of his/her office. Such highly confidential information may come into his/her possession prior to possession coming into that of the Council. The Vice-President shall ensure that such highly confidential information is only disclosed in accordance with proper process and shall respect such highly confidential information when they vacate the office of Vice-President. 7. Advisory Committees of the Council 7.1 Procedure for appointment of Advisory Committees of Council Advisory Committees of Council can be made up of both Council and non-council members who are co-opted onto the Committee. All appointments to Advisory Committees are made by the Council. Each Committee should develop a competency framework in which the Committee can identify the mix of skills, expertise, knowledge, experience, perspective and qualities that it considers are necessary, relevant or desirable to its business and functions. The Committee should then identify areas of competence, or qualities which may be supplementary to the Committee s functioning. Issues of diversity, such as mix of gender, background etc. may be relevant. In addition, the contribution, perspective or participation of sectors of the public, pharmacy profession, health service providers, or other stakeholders may be relevant and desirable. The Council has appointed a Nominations Sub-group to oversee the appointments process and make recommendations to Council. 7.2 Period of Appointment to Advisory Committees and Rotation Individuals appointed to Advisory Committees should serve a term of two years from the date of their appointment, with the eligibility to be appointed for a further term of two years on that Committee. The Council considers it desirable that such members rotate between Committees also, where appropriate. 7.3 Effectiveness of Advisory Committees of Council The effectiveness of Advisory Committees and of individual Committee members will be reviewed on an annual basis. Attendance at Advisory Committee meetings will be reported on in the Annual Report. 7.4 Function of the Committee Chairperson 24
25 1. Liaises with the Secretary to the Advisory Committee (generally the Head of Department) on developing the work programme and forward planning of agendas; 2. Submits any items for the agenda to the Secretary to the Committee not less than two weeks before the meeting and should be consulted on the draft agenda, in advance of circulation to the wider Committee, whenever possible; 3. Manages the business of the Committee jointly with the Secretary to the Committee; 4. Chairs meetings of the Committee; 5. Manages time, ensuring adequate, but controlled, consideration of issues without jeopardising the completion of the agenda; 6. Ensures that clear and unambiguous decisions are taken by the Committee moving it towards resolution of its stated aims and objectives and not towards the personal objectives of individual members; 7. Encourages members of the Committee to take collective responsibility for what has been agreed; 8. Regularly liaises with the Secretary to the Committee and builds up a good working relationship with appropriate staff; 9. Ensures full participation of all Committee members including co-opted members and of the Executive; 10. Notifies the Secretary to the Committee if unable to chair a meeting; 11. Approves the draft minutes of meetings before their circulation; 12. Monitors implementation of Committee decisions; 13. Decides in conjunction with the Secretary to the Committee those matters which fall within the Committee s responsibility; 14. Deals with issues which arise between Committee meetings which require an urgent response in liaison with the Secretary; 15. Participates in the Chairpersons Forum; 16. Presents and support the Committee s recommendations; 17. Contributes to general forward planning of agenda items; 18. Assists the Committee to review and assess its performance; and, 19. Gives an update on Committee activities to Council at every Council meeting and if they are not present at the Council meeting, nominates an individual from the Committee to give the update. 7.5 Responsibilities of Advisory Committee Members 1. Supports policies and strategy agreed at Council and works positively and constructively to progress them; 2. Takes responsibility for addressing the items that appear on the agenda by: a) Reading the papers beforehand; b) Being disciplined enough not to deviate from the agenda item; c) Contributing to discussions with no personal objectives in mind; 3. Participates fully in the discussions concerning the implementation of policy agreed by Council generating new ideas and building on those of others; 4. Clarifies the issues to be tackled and works with the Chairperson and Committee members to resolve them; 5. Ensures clear and collective decisions have been reached and action points are attributable to individuals; 6. Monitors, with others, implementation of established policies; and, 7. Works constructively as part of a team. 25
26 8. Key Roles and Functions of the Registrar (Chief Officer), senior management team and employees of the PSI 8.1 Appointment of the Registrar The Council appoints a Chief Officer of the PSI, to be known as the Registrar of the PSI. The Registrar is paid by the PSI such remuneration and allowances as the Council, with the approval of the Minister for Health and the consent of the Department of Public Expenditure and Reform, determines from time to time. The Registrar is employed on such other terms and conditions as the Council, with the approval of the Minister for Health and the consent of the Department of Public Expenditure and reform. The Registrar fulfils the role of Secretary to the Council. 8.2 Appointment of an Acting Registrar The Registrar may in his or her absence appoint a member of the Senior Management Team as Acting Registrar for a specified period of time. 8.3 Temporary vacancy in the Office of Registrar If a temporary vacancy arises in the office of Registrar the President of the Council must inform the Minister for Health immediately. The Council should then appoint, a suitable person to undertake the role, following an internal recruitment process, pending the outcome of a full competition process and inform the Minister for Health. A permanent appointment should be made as soon as possible following a competition under the auspices of the Public Appointments Service. The Council of the PSI should appoint a Registrar following a recommendation from the Public Appointments Service subject to the Terms and Conditions as the Minister for Health and the Department of Public Expenditure and Reform determines. 8.4 Specific functions, powers and obligations of the Registrar Functions of the Registrar 1. The Registrar ensures that the Council meets not less than four times a year; 2. The Registrar shall keep the registers, manage and control the administration and business of the PSI and the Council, and perform such other functions as may be determined by the Council; 3. The Registrar is responsible for supporting the Council and the Advisory Committees; 4. The Registrar is responsible for appointments including recruitments, direction and management of employees. The operation of the Council resides with the management and employees of the PSI, effected through the Registrar; 5. Designated PSI employees are individually accountable for assigned areas of delivery and control and are directly responsible to the Registrar. Designated employees may be required to report periodically to the Council thereon at the Registrars request. 6. The Registrar ensures that an objective procedure for a review of the performance of the Council and of the Advisory Committees is in place and effected regularly; 26
BYLAWS NATIONAL ASSOCIATION OF SPECIALTY PHARMACY, INC. Effective as of September 8, 2017 ARTICLE I GENERAL
BYLAWS OF NATIONAL ASSOCIATION OF SPECIALTY PHARMACY, INC. Effective as of September 8, 2017 ARTICLE I GENERAL 1.1 Name. The name of the corporation is National Association of Specialty Pharmacy, Inc.
Annex A EXECUTIVE COMMITTEE I. Constitution The Executive Committee shall be established by the Board of Directors (BOD) of Banco De Oro Unibank, Inc. (BDO Unibank). It is an extension of the BDO Unibank